ROCKET PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2014 to 2023.
  • Rocket Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2024 was $471K, a 0.43% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Interest Expense for the twelve months ending September 30, 2024 was $1.88M, a 0.53% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.88M, a 0.7% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.86M, a 37.5% decline from 2021.
  • Rocket Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.98M, a 57.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.88M +$13K +0.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $1.86M -$1.12M -37.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.98M -$3.99M -57.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $6.97M +$1.01M +16.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $5.96M -$81K -1.34% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.04M +$6.04M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 $0 -$1.23M -100% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 $1.23M +$250K +25.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-16
2014 $980K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.